e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Excess medical costs in patients with asthma and the role of comorbidity
Wenjia Chen, Larry D. Lynd, J. Mark FitzGerald, Carlo A. Marra, Robert Balshaw, Teresa To, Hamid Tavakoli, Mohsen Sadatsafavi, for the Canadian Respiratory Research Network
Source:
Eur Respir J 2016; 48: 1584-1592
Journal Issue:
December
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Wenjia Chen, Larry D. Lynd, J. Mark FitzGerald, Carlo A. Marra, Robert Balshaw, Teresa To, Hamid Tavakoli, Mohsen Sadatsafavi, for the Canadian Respiratory Research Network. Excess medical costs in patients with asthma and the role of comorbidity. Eur Respir J 2016; 48: 1584-1592
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Extent of uncontrolled disease and associated medical costs in severe asthma in the Netherlands
Source: Annual Congress 2007 - Epidemiology of asthma
Year: 2007
COPD - comorbidities and their impact on the need of medical care
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
Higher resource use and lower asthma-related QOL in patients with severe or difficult-to-treat asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 296s
Year: 2003
Socioeconomic biases in asthma control and specialist referral of possible severe asthma
Source: Eur Respir J, 58 (6) 2100741; 10.1183/13993003.00741-2021
Year: 2021
Role of a prolonged inpatient admission when evaluating children with problematic severe asthma
Source: Eur Respir J, 51 (2) 1701061; 10.1183/13993003.01061-2017
Year: 2018
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Current smoking and low HRQoL as strong predictive factors for acute care among elderly asthma patients
Source: Annual Congress 2012 - Asthma management
Year: 2012
Prevalence of asthma characteristics in COPD patients in a Dutch well-established asthma/COPD service for primary care
Source: International Congress 2019 – Diagnosis and assessment of airway diseases in primary care
Year: 2019
Potential use of a COPD ²e-passport² for assessing hospitalization risks during outpatient visits
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Hospitalisation of COPD patients due to comorbidity
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008
Omalizumab decreases medical resource utilisation in patients with severe allergic asthma in an Italian real-life setting
Source: International Congress 2017 – Asthma management
Year: 2017
Gender aspect of comorbidities in COPD patients in primary care.
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Prevalence of comorbidity in patients with COPD and its effect on mortality
Source: Annual Congress 2003 - Staging and outcome in COPD
Year: 2003
Incidence and impact of healthcare defined exacerbation amongst a cohort of primary care COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004
Depressive symptoms among COPD patients are associated with increased healthcare utilization
Source: Eur Respir J 2004; 24: Suppl. 48, 15s
Year: 2004
Predictors of psychiatric disorders in COPD patients
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013
Impact of definition when assessing the cumulative incidence of exacerbation amongst a cohort of primary care COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004
The impact of paramedics‘ education on controlled oxygen prescribing for patients with acute exacerbations of COPD during ambulance transfers on outcomes
Source: Annual Congress 2012 - Multidisciplinary critical care
Year: 2012
Do cardiovascular drugs reduce exacerbations rates in primary care patients with COPD?
Source: Eur Respir J 2007; 30: Suppl. 51, 126s
Year: 2007
Disease-specific medication, patient-reported diagnoses and their relation to COPD severity for common comorbidities in COPD
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept